Articles by Lynn Baglyos

Immunogenicity of ALVAC-HIV vCP1521 in Infants of HIV-1–Infected Women in Uganda (HPTN 027): The First Pediatric HIV Vaccine Trial in Africa

Kaleebu, Pontiano; Njai, Harr Freeya; Wang, Lei; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(3):268-277, March 1, 2014.

Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV-Exposed Infants in Uganda: Results From the First HIV Vaccine Trial in Infants in Africa

Kintu, Kenneth; Andrew, Philip; Musoke, Philippa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(1):1-8, May 1, 2013.

A Phase 1/2 Comparative Vaccine Trial of the Safety and Immunogenicity of a CRF01_AE (Subtype E) Candidate Vaccine: ALVAC-HIV (vCP1521) Prime With Oligomeric gp160...

Thongcharoen, Prasert; Suriyanon, Vinai; Paris, Robert M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(1):48-55, September 1, 2007.

Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120: Negative Results Fail to Trigger a Phase 3 Correlates Trial

Russell, Nina D; Graham, Barney S; Keefer, Michael C; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(2):203-212, February 1, 2007.